J&J unit acquires RespiVert
- June 01, 2010
Johnson & Johnson’s Centocor Ortho Biotech unit said Tuesday it bought RespiVert Ltd., a company developing treatments for asthma and other lung diseases. Respivert is testing anti-inflammatory drugs that are intended ... Read More